In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.

Cigna Group plans to limit patients’ out-of-pocket expenses for medications as the insurer faces pressure from Washington ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

According to Bloomberg, a top Cigna executive said it will prevent patients from paying the full list price for drugs, or more than their employer has contributed.

The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.

Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...

Even though some of these "middlemen" are supposed to obtain drugs at a lower price for their clients (ie, insurance companies, pharmacies, hospital systems, et cetera), some argue their fees can ...

I don’t feel bad for lawmakers very often. But trying to solve the national problem of high health care costs and ...

I don’t feel bad for lawmakers very often. But trying to solve the national problem of high health care costs and accessibility from a state-level perspective is rough. And almost impossible.